Psychedelic Therapy in Georgia, Tennessee & the Carolinas: Access Now
Last Updated: May 2026 Psychedelic therapy Georgia seekers can access today is primarily ketamine-based, with FDA-cleared options available in Atlanta, Nashville, and Asheville. Psilocybin remains a...
Psychedelic Therapy in Pennsylvania: Philadelphia, Pittsburgh & Legal Access
Psychedelic therapy in Pennsylvania is at an early but real stage of development. Ketamine is the only legally available psychedelic-assisted treatment within the state right now,...
Psychedelic Therapy in Arizona: Ketamine, Laws, and Support
Last Updated: May 2026 Psychedelic therapy in Arizona currently means ketamine, which is legal, widely available in Scottsdale and Phoenix, and supported by a growing number...
Ibogaine Opioid Treatment Research: What 2025-2026 Studies Found
Ibogaine opioid treatment research has moved significantly forward in 2025 and 2026, with new clinical data, a landmark $50 million Texas state investment, and a federal...
Psychedelic Therapy Washington DC, Maryland & Virginia: 2026 Guide
Last Updated: May 2026 If you’re looking for psychedelic therapy in Washington DC, Maryland, or Virginia (DMV), your clearest option right now is ketamine, which is...
Psychedelic Therapy in New York City: Ketamine, Legal Options, and What’s Next
Last Updated: May 2026 Psychedelic therapy in New York City is a real and growing option, but the legal landscape is still uneven. Ketamine therapy is...
Oregon Psilocybin Services: What’s Available, How It Works, and What It Costs
Oregon psilocybin services are legally available to any adult 21 or older, including visitors from out of state. No prescription or residency is required. Sessions take...
Psilocybin PTSD Therapy: What the 2026 Clinical Evidence Shows
Psilocybin PTSD therapy is no longer a fringe concept. A growing body of clinical research, including Phase 2 trials published in 2025, shows that a single...
Psychedelic Therapy California 2026: What’s Legal and What’s Not
Last Updated: May 2026 Psychedelic therapy in California is a complicated picture in 2026. Ketamine is the one legally accessible option through licensed medical providers, while...
MDMA Therapy FDA Decision, What the Rejection Letter Means for Seekers
The FDA rejected Lykos Therapeutics’ application for MDMA-assisted therapy for PTSD, citing three specific concerns: gaps in safety reporting, insufficient evidence that benefits lasted over time,...
Ready to take the next step?
Start with a complimentary conversation, or take the two-minute self-evaluation to see if this is your moment.